Aspen Pharmacare Limited (APNHY)
Aspen Pharmacare Statistics
Share Statistics
Aspen Pharmacare has 444.23M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 444.23M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 358.37M |
| Failed to Deliver (FTD) Shares | 38 |
| FTD / Avg. Volume | 4.2% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 22.73 and the forward PE ratio is null. Aspen Pharmacare's PEG ratio is -1.44.
| PE Ratio | 22.73 |
| Forward PE | n/a |
| PS Ratio | 2.24 |
| Forward PS | n/a |
| PB Ratio | 1.18 |
| P/FCF Ratio | 145.09 |
| PEG Ratio | -1.44 |
Enterprise Valuation
Aspen Pharmacare has an Enterprise Value (EV) of 124.23B.
| EV / Sales | 2.78 |
| EV / EBITDA | 12.54 |
| EV / EBIT | 19.96 |
| EV / FCF | 180.04 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.43.
| Current Ratio | 1.81 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 3.68 |
| Debt / FCF | 52.83 |
| Interest Coverage | 3.14 |
Financial Efficiency
Return on Equity is 5.19% and Return on Invested Capital is 4.28%.
| Return on Equity | 5.19% |
| Return on Assets | 3.16% |
| Return on Invested Capital | 4.28% |
| Revenue Per Employee | $5.04M |
| Profits Per Employee | $496.67K |
| Employee Count | 8,867 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.4 |
Taxes
| Income Tax | 1.31B |
| Effective Tax Rate | 22.93% |
Stock Price Statistics
The stock price has increased by -48.32% in the last 52 weeks. The beta is 0.58, so Aspen Pharmacare's price volatility has been higher than the market average.
| Beta | 0.58 |
| 52-Week Price Change | -48.32% |
| 50-Day Moving Average | 8.69 |
| 200-Day Moving Average | 10.09 |
| Relative Strength Index (RSI) | 27.89 |
| Average Volume (20 Days) | 904 |
Income Statement
In the last 12 months, Aspen Pharmacare had revenue of 44.71B and earned 4.4B in profits. Earnings per share was 9.91.
| Revenue | 44.71B |
| Gross Profit | 19.42B |
| Operating Income | 7B |
| Net Income | 4.4B |
| EBITDA | 9.9B |
| EBIT | 7.94B |
| Earnings Per Share (EPS) | 9.91 |
Balance Sheet
The company has 12.34B in cash and 36.46B in debt, giving a net cash position of -24.12B.
| Cash & Cash Equivalents | 12.34B |
| Total Debt | 36.46B |
| Net Cash | -24.12B |
| Retained Earnings | 60.76B |
| Total Assets | 139.16B |
| Working Capital | 19.71B |
Cash Flow
In the last 12 months, operating cash flow was 6.22B and capital expenditures -5.54B, giving a free cash flow of 690M.
| Operating Cash Flow | 6.22B |
| Capital Expenditures | -5.54B |
| Free Cash Flow | 690M |
| FCF Per Share | 1.55 |
Margins
Gross margin is 43.43%, with operating and profit margins of 15.65% and 9.85%.
| Gross Margin | 43.43% |
| Operating Margin | 15.65% |
| Pretax Margin | 12.78% |
| Profit Margin | 9.85% |
| EBITDA Margin | 22.16% |
| EBIT Margin | 15.65% |
| FCF Margin | 1.54% |
Dividends & Yields
APNHY pays an annual dividend of $0.38, which amounts to a dividend yield of 1.83%.
| Dividend Per Share | $0.38 |
| Dividend Yield | 1.83% |
| Dividend Growth (YoY) | 8.7% |
| Payout Ratio | 71.11% |
| Earnings Yield | 4.4% |
| FCF Yield | 0.69% |
Analyst Forecast
Currently there are no analyst rating for APNHY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 2, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Nov 2, 2012 |
| Split Type | forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | 1.83 |
| Piotroski F-Score | 7 |